Use of NovoSeven® in Active Variceal Bleeding
NCT00154492
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
265
Enrollment
INDUSTRY
Sponsor class
Conditions
Acquired Bleeding Disorder
Cirrhosis
Interventions
DRUG:
activated recombinant human factor VII
Sponsor
Novo Nordisk A/S